Literature DB >> 2540025

Subclinical alveolar inflammation in rheumatoid arthritis: superoxide anion, neutrophil chemotactic activity and fibronectin generation by alveolar macrophages.

T Perez1, J M Farre, P Gosset, B Wallaert, B Duquesnoy, C Voisin, B Delcambre, A B Tonnel.   

Abstract

Interstitial lung disease (ILD) can be detected by pulmonary function testing (PFT) in 30-40% of rheumatoid arthritis (RA) patients. We assessed by bronchoalveolar lavage (BAL) the patterns of alveolitis in 21 RA patients: group 1 comprised 12 patients without evidence of ILD, and group 29 patients with clinical ILD defined by abnormal pulmonary function tests and/or chest X-ray. Cellular characteristics of BAL were studied in both groups. In addition, alveolar macrophages (AM) from patients in group 1 were isolated, and three parameters of cellular activation were studied: superoxide anion, fibronectin and neutrophil chemotactic activity generation. Total cell counts were not increased in group 1 but significantly increased in group 2 compared to controls. In group 1, 5/12 patients had elevated lymphocyte percentage (greater than 18%) suggesting subclinical lymphocyte alveolitis. In contrast, neutrophil alveolitis (greater than 4%) was found in 7/9 patients in group 2, mean percentage 12.9 +/- 4.2, compared with 1.2 +/- 6.4% in controls and 1.9 +/- 0.5% in group 1. These changes were not correlated with disease duration nor rheumatoid factor titres. Marked elevation of lymphocyte percentage was observed in patients with abnormal serum beta-2-microglobulin. Alveolar macrophages from group 1 patients released increased amounts of superoxide anion (7260 +/- 2700 vs controls 850 +/- 120 URL/5.10(5) cells), neutrophil chemotactic activity (21 +/- 4.8 vs controls 8.1 +/- 0.7 cells/HPF), and fibronectin (6.1 +/- 1.6 vs controls 1.3 +/- 0.2 ng.10(6) cells/hour). Whether or not lymphocyte alveolitis and/or AM dysfunction are pathogenic mechanisms of subsequent interstitial lung disease in patients who are still free of symptoms remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540025

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

Review 1.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  How common is methotrexate pneumonitis? A large prospective study investigates.

Authors:  Navtej Sathi; Batsirai Chikura; Viswanath V Kaushik; Rose Wiswell; Julie K Dawson
Journal:  Clin Rheumatol       Date:  2011-06-03       Impact factor: 2.980

3.  Exposure to peat dust: acute effects on lung function and content of bronchoalveolar lavage fluid.

Authors:  T Sandström; B Kolmodin-Hedman; M C Ledin; L Bjermer; S Hörnqvist-Bylund; N Stjernberg
Journal:  Br J Ind Med       Date:  1991-11

4.  Bronchoalveolar lavage in ankylosing spondylitis.

Authors:  D Wendling; J C Dalphin; B Toson; A Depierre; M Guidet
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

Review 5.  Subclinical alveolitis in immunologic systemic disorders.

Authors:  B Wallaert
Journal:  Lung       Date:  1990       Impact factor: 2.584

6.  Radiological and functional assessment of pulmonary involvement in the rheumatoid arthritis patients.

Authors:  Fikret Kanat; Funda Levendoglu; Turgut Teke
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

7.  Effects of an inhaled corticosteroid, budesonide, on alveolar macrophage function in smokers.

Authors:  H Bergstrand; A Björnson; E Blaschke; R Brattsand; A Eklund; K Larsson; M Linden
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

8.  Imaging of pulmonary disease in rheumatoid arthritis using J001X scintigraphy: preliminary results.

Authors:  P Goupille; P Diot; J P Valat; E Lemarie; C Valat; E Asquier; A Delarue; A Le Pape
Journal:  Eur J Nucl Med       Date:  1995-12

Review 9.  Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease.

Authors:  So My Koo; Song Yee Kim; Sun Mi Choi; Hyun Kyung Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2019-05-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.